Fundz

Who to call at InnoCare Pharma, and when

Fundz watches for the moments InnoCare Pharma starts buying, and tells you who to reach.

  • An alert the day InnoCare Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InnoCare Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InnoCare Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

InnoCare Pharma enters a strategic research collaboration and licensing agreement with Eli Lilly to develop new medicines.

Sep 24, 2026

Contract Type

partnership

BeijingBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Description

InnoCare Pharma and Eli Lilly have announced a partnership aimed at developing new medicines, with potential payments reaching about $3.35 billion. Under the agreement, InnoCare will utilize its drug discovery platform for research against multiple targets.

Quick answer

InnoCare Pharma enters a strategic research collaboration and licensing agreement with Eli Lilly to develop new medicines. (September 24, 2026). InnoCare Pharma is based in Beijing, Beijing, China.

What agreement did InnoCare Pharma announce on September 24, 2026?
InnoCare Pharma and Eli Lilly have announced a partnership aimed at developing new medicines, with potential payments reaching about $3.35 billion. Under the agreement, InnoCare will utilize its drug discovery platform for research against multiple targets.
What does InnoCare Pharma do?
InnoCare Pharma is a leading biopharmaceutical company that focuses on the treatment of cancer and autoimmune diseases.
Where is InnoCare Pharma based?
InnoCare Pharma is based in Beijing, Beijing, China.
Which similar companies announced agreements around the same time?
YD Bio Limited (October 20, 2026), Alexion (October 29, 2026), AbbVie Inc. (November 3, 2026) and Hansoh Pharma (October 19, 2026) also announced agreements within 45 days of InnoCare Pharma.

Source: Fundz verified event record.

Other recent agreements in Medical and Therapeutics

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

InnoCare Pharma

Location

Beijing, Beijing, China

About

InnoCare Pharma is a leading biopharmaceutical company that focuses on the treatment of cancer and autoimmune diseases. The company is committed to discovering, developing, and commercializing first-in-class and best-in-class drugs to address unmet medical needs in China and globally. With branches in various cities including Beijing and Hong Kong, InnoCare is actively involved in advancing innovative therapies. They aim to improve the quality of life for patients suffering from serious health conditions.

Related People

Yi
Likely contact at this company
••••••••@••••••••

See Yi's verified email →

Ivan
Likely contact at this company
••••••••@••••••••

See Ivan's verified email →

Alina
Likely contact at this company
••••••••@••••••••

See Alina's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for InnoCare Pharma's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

InnoCare Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.